These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 33132894)

  • 41. Interrelationship between the 5-lipoxygenase pathway and microbial dysbiosis in the progression of Alzheimer's disease.
    Mathis SP; Bodduluri SR; Haribabu B
    Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Sep; 1866(9):158982. PubMed ID: 34062254
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fecal Microbiota Transplantation: A Microbiome Modulation Technique for Alzheimer's Disease.
    Nandwana V; Debbarma S
    Cureus; 2021 Jul; 13(7):e16503. PubMed ID: 34430117
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gut microbial involvement in Alzheimer's disease pathogenesis.
    Zhang Y; Geng R; Tu Q
    Aging (Albany NY); 2021 May; 13(9):13359-13371. PubMed ID: 33971619
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gut dysbiosis aggravates cognitive deficits, amyloid pathology and lipid metabolism dysregulation in a transgenic mouse model of Alzheimer's disease.
    Qu C; Xu QQ; Yang W; Zhong M; Yuan Q; Xian YF; Lin ZX
    J Pharm Anal; 2023 Dec; 13(12):1526-1547. PubMed ID: 38223452
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Probiotic supplement as a promising strategy in early tau pathology prevention: Focusing on GSK-3β?
    Flynn CM; Yuan Q
    Front Neurosci; 2023; 17():1159314. PubMed ID: 37034173
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pathways linking microbiota-gut-brain axis with neuroinflammatory mechanisms in Alzheimer's pathophysiology.
    Hochuli N; Kadyan S; Park G; Patoine C; Nagpal R
    Microbiome Res Rep; 2024; 3(1):9. PubMed ID: 38455083
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Endocannabinoid System: A Bridge between Alzheimer's Disease and Gut Microbiota.
    Bisogno T; Lauritano A; Piscitelli F
    Life (Basel); 2021 Sep; 11(9):. PubMed ID: 34575083
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structural and Functional Dysbiosis of Fecal Microbiota in Chinese Patients With Alzheimer's Disease.
    Ling Z; Zhu M; Yan X; Cheng Y; Shao L; Liu X; Jiang R; Wu S
    Front Cell Dev Biol; 2020; 8():634069. PubMed ID: 33614635
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gut Microbiota is an Impact Factor based on the Brain-Gut Axis to Alzheimer's Disease: A Systematic Review.
    Zou B; Li J; Ma RX; Cheng XY; Ma RY; Zhou TY; Wu ZQ; Yao Y; Li J
    Aging Dis; 2023 Jun; 14(3):964-1678. PubMed ID: 37191418
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Microbiota-gut-brain axis and related therapeutics in Alzheimer's disease: prospects for multitherapy and inflammation control.
    Li J; Zhang F; Zhao L; Dong C
    Rev Neurosci; 2023 Aug; 34(6):695-718. PubMed ID: 37076953
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota.
    Li B; He Y; Ma J; Huang P; Du J; Cao L; Wang Y; Xiao Q; Tang H; Chen S
    Alzheimers Dement; 2019 Oct; 15(10):1357-1366. PubMed ID: 31434623
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of Lactobacillus dominance modified by Korean Red Ginseng on the improvement of Alzheimer's disease in mice.
    Lee M; Lee SH; Kim MS; Ahn KS; Kim M
    J Ginseng Res; 2022 May; 46(3):464-472. PubMed ID: 35600775
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Microbiota Alterations in Alzheimer's Disease: Involvement of the Kynurenine Pathway and Inflammation.
    Garcez ML; Jacobs KR; Guillemin GJ
    Neurotox Res; 2019 Aug; 36(2):424-436. PubMed ID: 31089885
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Role of Gut Microbiota in the Neuroprotective Effects of Selenium in Alzheimer's Disease.
    Skalny AV; Aschner M; Santamaria A; Filippini T; Gritsenko VA; Tizabi Y; Zhang F; Guo X; Rocha JBT; Tinkov AA
    Mol Neurobiol; 2024 Jul; ():. PubMed ID: 39012446
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alzheimer's Disease Microbiome Is Associated with Dysregulation of the Anti-Inflammatory P-Glycoprotein Pathway.
    Haran JP; Bhattarai SK; Foley SE; Dutta P; Ward DV; Bucci V; McCormick BA
    mBio; 2019 May; 10(3):. PubMed ID: 31064831
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Gut Microbiota-Brain Axis: A New Frontier on Neuropsychiatric Disorders.
    Queiroz SAL; Ton AMM; Pereira TMC; Campagnaro BP; Martinelli L; Picos A; Campos-Toimil M; Vasquez EC
    Front Psychiatry; 2022; 13():872594. PubMed ID: 35722583
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
    Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
    Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neuroinflammation and the Gut Microbiota: Possible Alternative Therapeutic Targets to Counteract Alzheimer's Disease?
    Cerovic M; Forloni G; Balducci C
    Front Aging Neurosci; 2019; 11():284. PubMed ID: 31680937
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of Anti-amyloid-β Monoclonal Antibodies on the Pathology and Clinical Profile of Alzheimer's Disease: A Focus on Aducanumab and Lecanemab.
    Shi M; Chu F; Zhu F; Zhu J
    Front Aging Neurosci; 2022; 14():870517. PubMed ID: 35493943
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.